Patient Monitoring Wearable Shipments to Grow by 32% by 2021
February 2, 2017 | ABI ResearchEstimated reading time: 1 minute
A surge in healthcare patient monitoring wearables will soon help reduce readmission risks and better prevent the occurrence of serious medical traumas, alleviating growing performance pressures on healthcare services. ABI Research forecasts the patient monitoring wearable market, which includes remote and on-site devices, will grow from 8 million shipments in 2016 to 33 million in 2021. Device types are diverse and include staples like blood pressure monitors, continuous glucose monitors, and pulse oximeters, as well as newer devices like Fatigue Science’s fatigue monitoring wearable.
“While previously professional-grade patient monitoring largely limited itself to a doctor’s rounds, new wearables allow medical professionals to remotely and continuously monitor patients in the hospital and beyond,” says Stephanie Lawrence, Research Analyst at ABI Research. “The devices send real-time alerts regarding any condition deteriorations or fluctuations, in effect reducing response times to potentially life-threatening changes and saving the healthcare system resources in the long term.”
On-site professional healthcare monitoring wearables, such as those by Philips Healthcare, allow medical professionals to work with a larger base of patients, as the devices continuously update doctors throughout the day on patients’ vitals and overall conditions without the need for physical check-ins. The wearables also, in effect, help to ensure that doctors do not overlook any slight changes in condition before granting patients release.
Beyond the hospital, remote patient monitoring wearables, such as blood pressure monitors and telemedicine products by A&D Medical, then provide healthcare professionals with continued access to their patients’ health, which would have otherwise been inaccessible once they left the confines of the hospital. As such, doctors can now, like with on-site treatment, monitor their patients’ conditions and better diagnose any treatment adjustments that may be necessary on the path to recovery.
A&D Medical, Medtronic, Nonin Medical, and Philips Healthcare lead the market, with startups like Fatigue Science, Health Care Originals, and Qardio beginning to challenge the incumbents and diversify the competitive landscape in offering solutions to treat specific medical conditions.
“Remote patient monitoring devices will see strong growth of nearly 35% by 2021, and will take up a 60% share of the patient monitoring market as healthcare professionals embrace the benefits that come with the ability to remotely and continuously monitor patients’ vitals,” concludes Lawrence.
Testimonial
"In a year when every marketing dollar mattered, I chose to keep I-Connect007 in our 2025 plan. Their commitment to high-quality, insightful content aligns with Koh Young’s values and helps readers navigate a changing industry. "
Brent Fischthal - Koh YoungSuggested Items
Medical Device OEM/ODM/CDMO Industry Forecast: CAGR of 7.5% to 2031 Amid Growing Healthcare Innovation
09/17/2025 | PRNewswireThe global market for Medical Device OEM/ODM/CDMO was valued at US$ 115434 million in the year 2024 and is projected to reach a revised size of US$ 191760 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Armstrong Asia Signs MOU with Checkmate Capital Group to Explore Strategic Collaboration
09/15/2025 | GlobeNewswireArmstrong Asia, a leading Singapore-based manufacturer of flexible material solutions with 16 factories across 7 countries in Asia, has signed a Memorandum of Understanding (MOU) with Checkmate Capital Group, LLC (“Checkmate Capital”), a U.S.-based investment and advisory firm active in the Asia-Pacific and North American regions, focused on cross-border transactions in the life sciences, medical technology, and other industries.
Nordson MEDICAL Divests Contract Manufacturing, Refocuses on Proprietary Components
09/03/2025 | BUSINESS WIRENordson Corporation has completed the divestiture of select product lines within its medical contract manufacturing business to Quasar Medical.
Medical Device Contract Manufacturing Market Worth $140.84 Billion by 2030 with 10.9% CAGR
08/25/2025 | PRNewswireThe global Medical Device Contract Manufacturing Market, valued at US$78.58 billion in 2024, stood at US$83.77 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$140.84 billion by the end of the period.
TT Electronics Achieves ISO 13485 Medical Certification at Mexicali EMS Facility
06/27/2025 | TT ElectronicsThis milestone underscores TT Electronics’ commitment to delivering high-quality, compliant, and reliable manufacturing solutions to its global customers in healthcare and life sciences.